Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03389620 · ClinicalTrials.gov registry record · Phase 2
Transforaminal Versus Lateralized Interlaminar Cervical Epidurals
A Phase 2 study of Cervicogenic Upper Extremity Radiculopathy, sponsored by Duke University.
- Completed
- Registry status
- Phase 2
- Development phase
- 74
- Enrollment target
- 1
- Study location
NCT03389620 is a Phase 2 study of Cervicogenic Upper Extremity Radiculopathy that has completed, run by Duke University. The registered enrollment target is 74 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03389620, a Phase 2 study of Cervicogenic Upper Extremity Radiculopathy, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 74 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare two methods of giving epidural steroid injections for nerve pain in the arm that comes from the neck. An epidural steroid injection can be given in two different ways, either in the back of the spine within the neck or in the neck next to the nerve root going to the arm. Both are standard medical treatments. The investigators would like to see how effective these treatments are, and if there are any differences in effectiveness or safety between these two routes.
Conditions Studied
Interventions
- DRUG dexamethasone
Study Locations (1)
North Carolina
- Duke Radiology and Orthopaedic Clinic - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2018-01-05 |
| Est. Completion | 2023-09-16 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03389620
The ClinicalTrials.gov registry entry for NCT03389620 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cervicogenic Upper Extremity Radiculopathy appearing as the primary indexed condition, and to 1 intervention - of which dexamethasone is the first listed.
NCT03389620 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT03389620 about?
NCT03389620 is a clinical study titled "Transforaminal Versus Lateralized Interlaminar Cervical Epidurals". The purpose of this study is to compare two methods of giving epidural steroid injections for nerve pain in the arm that comes from the neck. An epidural steroid injection can be given in two different ways, either in the back of the spine within the neck or in the neck next to the nerve root going ...
What is the current status of trial NCT03389620?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 74 participants. The study started on 2018-01-05. Estimated completion is 2023-09-16.
What conditions does trial NCT03389620 study?
This clinical trial studies the following conditions: Cervicogenic Upper Extremity Radiculopathy.
What interventions are being tested in trial NCT03389620?
The interventions under investigation include: dexamethasone (DRUG).
Who is sponsoring clinical trial NCT03389620?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03389620 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.